|
Volumn 47, Issue 6, 2012, Pages 441-442
|
Naltrexone: Posttraumatic stress disorder
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ADRENERGIC RECEPTOR BLOCKING AGENT;
AMFEBUTAMONE;
ANTICONVULSIVE AGENT;
ANTIDEPRESSANT AGENT;
CARBAMAZEPINE;
DISULFIRAM;
LAMOTRIGINE;
MIRTAZAPINE;
MONOAMINE OXIDASE INHIBITOR;
MOOD STABILIZER;
NALTREXONE;
NEFAZODONE;
OPIATE ANTAGONIST;
PLACEBO;
SEROTONIN UPTAKE INHIBITOR;
TOPIRAMATE;
TRAZODONE;
TRICYCLIC ANTIDEPRESSANT AGENT;
VALPROATE SEMISODIUM;
VALPROIC ACID;
VENLAFAXINE;
ABDOMINAL DISCOMFORT;
ADULT;
ALCOHOLISM;
ANGER;
ARTICLE;
CLINICAL PRACTICE;
COMORBIDITY;
CONSENSUS DEVELOPMENT;
DROWSINESS;
DRUG DOSE INCREASE;
DRUG INDICATION;
DRUG SAFETY;
HEADACHE;
HUMAN;
IRRITABILITY;
MAJOR CLINICAL STUDY;
NAUSEA;
OFF LABEL DRUG USE;
OPEN STUDY;
POSTTRAUMATIC STRESS DISORDER;
PRACTICE GUIDELINE;
PSYCHOPHARMACOTHERAPY;
RAGE;
RANDOMIZED CONTROLLED TRIAL (TOPIC);
SIDE EFFECT;
SYMPTOM;
TREATMENT OUTCOME;
TREMOR;
WEAKNESS;
|
EID: 84861864015
PISSN: 00185787
EISSN: 19451253
Source Type: Journal
DOI: 10.1310/hpj4706-441 Document Type: Article |
Times cited : (2)
|
References (8)
|